Start here
MCS: We Followed the Evidence. Here's Where It Leads.
The evidence does not support the old choice between “toxic load” and “it is psychological.” In consensus-defined MCS, the weight of evidence supports an…
Every page here opens with its answer. Each one weighs the studies by quality, keeps the strongest contrary evidence on the page, and says where this site stands. Start with the essay; the questions branch from it.
MCS: We Followed the Evidence. Here's Where It Leads.
The evidence does not support the old choice between “toxic load” and “it is psychological.” In consensus-defined MCS, the weight of evidence supports an…
Yes. Multiple Chemical Sensitivity is a real, physiological disorder in which low-level chemical exposures that most people tolerate produce reproducible…
No. In MCS as defined by the 1999 consensus criteria, the evidence supports a physiological, environmentally triggered disorder.
The brain is part of the system that is affected. It is not the author of the illness, and it is not a control panel you can operate.
No. An MCS reaction at a low exposure level does not by itself mean conventional toxic poisoning is occurring.
MCS begins with exposure. The weight of the evidence supports environmental initiation in susceptible people over any account in which the condition starts…
Pesticides are one of the recurring exposure categories in MCS onset histories and occupational research, and some have conventional neurotoxic effects. A serious initiating candidate in a subset of cases; not a universal explanation.
Solvents, fuels, paint fumes, exhaust and petroleum-related exposures recur throughout occupational and onset histories. Credible initiating or aggravating exposures in subsets of patients; they do not point to one toxicant or one simple toxic-load mechanism.
Water-damaged buildings, renovation, new construction and indoor VOC mixtures repeatedly appear in MCS onset and relapse histories. An important exposure context; it does not justify reducing every case to mold toxicity.
Exposure alone does not explain MCS. People sharing the same building or deployment have very different outcomes; genetics, prior exposures and autonomic and immune state are candidates, and no single factor explains the population.
No validated diagnostic test for MCS exists. That is a fact about the research, not about the illness. Dozens of candidate markers have been studied;
Environmental hyperresponsiveness is this network’s working research hypothesis for what MCS and its overlapping conditions may have in common: an acquired…
Published controlled evidence has not shown brain retraining to reverse MCS or reliably restore chemical tolerance.
Yes — for coping, fear, sleep and how you carry the illness, on the evidence of the one controlled trial. Not, on that same evidence, for the illness itself.
The strongest case that MCS is psychological rests on the provocation studies, and this site puts them front and center rather than hiding them.
A reference page. The 2006 review is cited in every argument about MCS, usually by people who have read the abstract. Here is what it contains.
Probably, for some people, and that is not a concession to the psychological camp.
The Gupta program’s MCS page states an eighty-five percent improvement in MCS "in our latest randomised controlled trial." The same page, two paragraphs…
A reference page. Every brain-based approach offered for MCS has a study behind its claims.
A treatment whose successes prove it and whose failures also prove it — because the failures did not believe enough — has removed itself from the world of…
How you think shapes how you live with MCS. That is true, it is in the pain literature, and it is in the one controlled trial.
Predictive coding, neurotags, somatic tracking and neural-circuit models are serious neuroscience, and they explain something real about chronic symptoms…
Reducing exposure is the one management strategy supported by every source we have: the consensus criteria that define the condition, the survey of 917…
It can. Sensitization and the spreading of sensitivities to new chemicals are well documented in MCS, and repeated exposure during a sensitized state is the…
People improve, sometimes substantially. Some regain considerable function and tolerance and stay well for years. Some relapse after a new exposure.
Yes. Hope is not the same as a promise, and this site will not make you a promise the evidence cannot keep.
Reducing exposure is the one management strategy supported by every source we have: the consensus criteria that define the condition, the survey of 917…
Exposure vigilance is the protective attention that develops after repeated, reproducible reactions. In MCS, caution is a consequence of the illness; it has not been shown to be its cause.
Because MCS is a sensitization that fluctuates, not a cured condition. People who have done well for years report being set back by a renovation, a new job…
No. Supervised re-exposure is not an established treatment for Multiple Chemical Sensitivity.
It is biologically plausible, supported at the level of cells and animals, and unproven in people.
Long COVID has produced, at scale and under observation, a condition that looks like the cluster MCS belongs to: post-exposure onset, multisystem symptoms…
MCS, EHS, MCAS, POTS and dysautonomia, ME/CFS, fibromyalgia, migraine, asthma and cough hypersensitivity, PTSD and TBI, Long COVID: they co-occur in the same…
Three results, in order. First, documented illness before awareness in hundreds of people: unexplained symptoms on a dated medical record, followed by later…
If people became sick before they knew an exposure had occurred or suspected chemicals, that chronology directly tests explanations based on expectation or fear at onset. It has barely been measured.
Because the research looked for one marker in small, inconsistently defined samples for thirty years, and MCS is not a one-marker condition.
PTSD and traumatic brain injury are useful comparisons for MCS because they show that very different initiating events — a psychological trauma, a physical…
Gulf War illness does not prove the mechanism of MCS, but it strongly supports the exposure-plus-susceptibility framework: exposed military populations, more MCS in Gulf-deployed cohorts, and PON1 gene-environment findings.
The research-method page. The provocation literature of 2006 asked whether people with MCS could identify a chemical.
TRPV1 and TRPA1 are leading biological candidates because they connect environmental irritants with cough, pain, neurogenic inflammation, and sensory…
MCS research contains reproducible-enough signals in oxidative stress, glutathione, and metabolic regulation to take redox biology seriously.
MCAS and chemical intolerance overlap, but that does not establish that MCAS causes most MCS or that most people with MCS have MCAS.
Small-fiber neuropathy is one of the most interesting objective findings in a selected MCS/chronic-pain cohort, but it is not yet an MCS biomarker.
Autonomic involvement is a serious MCS research lead, but MCS is not established as POTS and POTS is not established as the explanation for MCS.
No. MCS should not currently be called an autoimmune disease. Immune and inflammatory abnormalities are real enough to investigate, but no reproducibl
Brain imaging in MCS shows recurring differences in sensory and neural processing.
Every page above offers its own PDF. The full collection — the essay and all 45 questions — is one file.